Brief: BioNexus Gene Lab And Fidelion Announce Strategic Cross-Equity Partnership
30/07/2025 13:59
July 30 (Reuters) - BioNexus Gene Lab Corp BGLC.O: BIONEXUS GENE LAB CORP - CO AND FIDELION ANNOUNCE STRATEGIC CROSS-EQUITY PARTNERSHIP BIONEXUS GENE LAB CORP - UNDER TERM SHEET, TO BUY EQUITY STAKE IN FIDELION AND SECURE COMMERCIAL RIGHTS TO VITAGUARD IN ASEAN Source text: ID:nGNX130CnY Further company coverage: BGLC.O ((Reuters.Briefs@thomsonreuters.com;))